Santa Cruz Biotechnology supplies a comprehensive collection of VHX Antibodies for advancing research initiatives. Monoclonal VHX Antibodies are compatible with multiple experimental applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). VHX, or VHL-Homologous Protein, plays a central role in cellular processes such as hypoxia response and protein degradation. VHX function is essential for maintaining cellular homeostasis and regulating gene expression in response to oxygen levels. Understanding VHX mechanisms has significant implications for cancer biology and diseases linked to oxygen sensing and metabolic regulation. Researchers can utilize VHX monoclonal antibodies to explore oxygen-dependent cellular pathways and their impact on disease progression. Advanced detection methods, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates, enable precise visualization of VHX in various experimental settings. VHX research continues to reveal new insights into cellular adaptation to hypoxic conditions and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in uncovering new perspectives in VHX-related cellular mechanisms and their therapeutic applications.